Overview
SDGR market data
Price History
SDGR price chart · 1M
- O
- 19.59
- H
- 20.29
- L
- 19.59
- C
- 20.24
- Vol
- 30,163.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $19.59
- Previous Close
- $19.47
- Day High
- $20.29
- Day Low
- $19.59
- 52 Week High
- $20.48
- 52 Week Low
- $11.60
- 7 Day Return
- +3.29%
- 30 Day Return
- +32.34%
- 90 Day Return
- +32.95%
- 1 Year Return
- +71.92%
- Daily Notional Volume
- $610.3K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.41 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.69 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -21.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $10.95 – $23.02 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.4B · P/B 3.62 · P/S 5.30.
Company News
Schrodinger Sees FY Drug Discovery Revenue At $65M-$75MBenzinga · Aug 5, 2026, 9:05 PM
Schrodinger Q2 Adj. EPS $0.08 Beats $(0.48) Estimate, Sales $58.889M Beat $47.228M EstimateBenzinga · Aug 5, 2026, 8:09 PM
Schrödinger Announces Strategic Agreement With Bristol Myers Squibb To Deploy Bunsen Agentic AI Co-Scientist At Scale Across Its Research OrganizationBenzinga · Aug 5, 2026, 12:31 PM
Schrödinger Rolls Out Early Access Version Of BunsenBenzinga · Jul 27, 2026, 11:35 AM
Generative AI in Drug Discovery: Revolutionizing Pharmaceutical Research and DevelopmentGlobenewswire Inc · Jul 10, 2026, 3:15 PM
Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AIBenzinga · Jul 1, 2026, 11:55 AM
8-K filing — Schrodinger, Inc. (SDGR)SEC EDGAR · Jun 29, 2026, 8:29 PM
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath ItBenzinga · Jun 16, 2026, 1:15 PM
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool · Jun 2, 2026, 10:15 PM